Current development of COVID-19 diagnostics, vaccines and therapeutics

Microbes Infect. 2020 Jul-Aug;22(6-7):231-235. doi: 10.1016/j.micinf.2020.05.001. Epub 2020 May 6.

Abstract

A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019. The rapidly increasing number of cases has caused worldwide panic. In this review, we describe some currently applied diagnostic approaches, as well as therapeutics and vaccines, to prevent, treat and control further outbreaks of SARS-CoV-2 infection.

Keywords: Diagnostic approaches; SARS-CoV-2; Therapeutics; Vaccines.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus
  • COVID-19
  • COVID-19 Vaccines
  • China
  • Clinical Trials as Topic
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • Humans
  • Pandemics / prevention & control*
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / prevention & control*
  • SARS-CoV-2
  • Viral Vaccines / immunology*
  • World Health Organization

Substances

  • Antiviral Agents
  • COVID-19 Vaccines
  • Viral Vaccines